Our partnership with MJFF, BRAF and MEK inhibitors, and ChIP training

Our partnership with MJFF   We're working with The Michael J. Fox Foundation (MJFF) to break down barriers to Parkinson's disease research by providing critical reagents to key targets. Watch this video to learn more and find our range of reagents to support your next breakthrough.   Watch the video       BRAF and MEK inhibitors    Find out how BRAF V600E and immune target combination therapies are at the forefront of melanoma research.   Find out more   ChIP training   Sign up for our free, online ChIP training series and receive the support you need to develop your skills.   Sign up   Secret life of RNA in neurons   Professor Antonella Riccio discusses the mechanism for RNA transport processing in neurons.   Watch the talk

Discovered: 20 years of breakthroughs   Here are some of the game changers as nominated by you, the scientists   Discover more   Better antibodies power better assay kits   You know about our antibodies, but did you know we use those same antibodies in our assay kits?   Learn more

Antibody discovery   Abcam’s experts discuss the future for antibody discovery platforms and how they will contribute to personalized medicine.   See advantages   Bright fluorescent staining   Get bright staining and greater photostability using our Alexa Fluor® 488 secondary antibody.   Try it now